A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts
Mark C. Markowski, Hao Wang, Rana Sullivan, Irina Rifkind, Victoria J. Sinibaldi, Michael T. Schweizer, Benjamin A. Teply, Nduku Ngomba, Wei Fu, Michael A. Carducci, Channing J. Paller, Catherine H. Marshall, Mario A. Eisenberger, Jun Luo, Emmanuel S. Antonarakis, Samuel R. Denmeade
Topics & Concepts
MedicineEnzalutamideProstate cancerAbirateroneOncologyInternal medicineAndrogen deprivation therapyUrologyAndrogenAbiraterone acetateOpen labelCancerClinical trialAndrogen receptorHormoneProstate Cancer Treatment and ResearchAdvanced Breast Cancer TherapiesHormonal and reproductive studies